Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

IIT Roorkee Inaugurates Ashok Soota Molecular Medicine Facility at BSBE to Advance Translational Biomedical Research

This image opens in the lightbox

News provided by

SKAN Research Trust

17 Mar, 2026, 09:53 GMT

Share this article

Share toX

Share this article

Share toX

  • State-of-the-art facility to strengthen molecular diagnostics, precision medicine, and translational research
  • Industry-supported initiative reinforces academia–industry collaboration in life sciences

BENGALURU, India and ROORKEE, India, March 17, 2026 /PRNewswire/ -- The Indian Institute of Technology Roorkee (IIT Roorkee) inaugurated the Ashok Soota Molecular Medicine Facility at the Department of Biosciences and Bioengineering (BSBE), marking a significant step in strengthening advanced biomedical research infrastructure aligned with national healthcare priorities and global scientific advancements. The facility was inaugurated by Shri Ashok Soota, a distinguished Alumnus of IIT Roorkee and Chairman of SKAN Research Trust, in the presence of Prof. K. K. Pant, Director, IIT Roorkee, along with faculty members, researchers, and industry representatives.

Continue Reading
This image opens in the lightbox
IIT Roorkee Inaugurates Ashok Soota Molecular Medicine Facility at BSBE to Advance Translational Biomedical Research

Established as a state-of-the-art, integrated platform, the Ashok Soota Molecular Medicine Facility is designed to support drug discovery, biomolecular research, and the development of next-generation diagnostic tools. The facility enables researchers to move from decoding disease mechanisms and identifying biomolecular targets to experimental validation of lead molecules and assay development. By integrating expertise in protein science, molecular and cell biology, structural biology, biophysics, analytical profiling, and advanced imaging, the facility will support high-impact research across critical disease domains, including cancer, neurological disorders, metabolic diseases, and infectious diseases.

The facility houses advanced instrumentation supporting end-to-end workflows in molecular characterization and translational research, including Automated Protein Purification Systems (AKTA and Biorad/AKTA), HPLC and UPLC systems, GC-MS, Iso-Thermal Calorimeter (ITC), Flow Cytometer, Upright Confocal Microscope, Small-Angle X-ray Scattering (SAXS), Protein Crystallization Robot, CD Spectrometer, High Pressure Homogenizer/Cell Disruptor, and other high-precision analytical platforms. This comprehensive infrastructure significantly strengthens IIT Roorkee's capability in molecular diagnostics, structural validation, biomolecular interaction studies, and advanced assay development.

Addressing the gathering, Prof. K. K. Pant, Director, IIT Roorkee, said, "The Ashok Soota Molecular Medicine Facility significantly augments IIT Roorkee's research ecosystem in biosciences and bioengineering. The integration of advanced infrastructure with interdisciplinary expertise will accelerate translational research and contribute meaningfully to national priorities in healthcare innovation, precision medicine, and scientific self-reliance."

Shri Ashok Soota, distinguished alumnus of IIT Roorkee, stated, "The establishment of this facility underscores the importance of building strong research ecosystems that translate scientific discovery into societal impact. India possesses immense scientific talent, and it is equally critical to provide world-class infrastructure and collaborative platforms to enable innovation at scale. I am proud to see IIT Roorkee strengthening its capabilities in molecular diagnostics, precision medicine, and drug discovery, contributing to healthcare solutions of both national and global relevance."

Prof. Pravindra Kumar, Head, Institute Instrumentation Center, and Ashok Soota Institute Chair Professor, added, "This facility will serve as a collaborative research platform for faculty, scholars, and industry partners. It enhances our shared research infrastructure and strengthens IIT Roorkee's capacity to undertake globally competitive, interdisciplinary research in molecular medicine and translational biosciences."

With this initiative, IIT Roorkee continues to reinforce its commitment to advancing interdisciplinary research, fostering industry collaboration, and contributing to innovation-driven solutions in areas of strategic importance to national and global healthcare systems.

About IIT Roorkee (https://www.iitr.ac.in/)

IIT Roorkee is an institute of national importance imparting higher education in engineering, sciences, management, architecture and planning, and humanities and social sciences. Since its establishment in 1847, the Institute has played a vital role in providing the country with technical human resources and know-how.

Join IIT Roorkee on Twitter: www.twitter.com/iitroorkee
Join IIT Roorkee on Facebook: https://www.facebook.com/IITRoorkee.ICC/
Join IIT Roorkee on LinkedIn: https://www.linkedin.com/school/157269/admin/
IIT Roorkee Website: https://www.iitr.ac.in/

About Ashok Soota

Ashok Soota is a serial entrepreneur, philanthropist, institution builder and author. He is Chairman of Happiest Minds, Happiest Health and SKAN.

Ashok's philanthropic institutions are Ashirvadam (2011) and SKAN (2021). The mission of SKAN is 'Transforming The Future of Medicine. Impacting Millions of Lives'.

Happiest Health is a knowledge, diagnostic, healthcare and wellness enterprise. Happiest Health's unique business model is aimed at reforming and reimagining the healthcare sector. 

For Media Queries on SKAN, please contact:

Website: SKANrt.in | contactus@skanrt.in

Photo: https://mma.prnewswire.com/media/2935788/Inauguration_ASMMF_Skan.jpg
Logo: https://mma.prnewswire.com/media/2935789/Skan_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.